XML 19 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
Total
License Agreement
Common Stock
Common Stock
License Agreement
Additional Paid-in Capital
Additional Paid-in Capital
License Agreement
Accumulated Deficit
Beginning balance at Dec. 31, 2017 $ 16,717,223   $ 2,549   $ 93,299,517   $ (76,584,843)
Balance (in shares) at Dec. 31, 2017     25,492,992        
Stock-based compensation 1,754,974       1,754,974    
Issuance of common stock upon exercise of options 380,322   $ 29   380,293    
Issuance of common stock upon exercise of options (in shares)     278,925        
Exercise of warrants 131,703   $ 10   131,693    
Exercise of warrants (in shares)     101,310        
Issuance of warrants upon debt financing 37,842       37,842    
Issuance of common stock upon financing 12,881,321   $ 421   12,880,900    
Issuance of common stock upon financing (in shares)     4,213,986        
Net loss (30,965,464)           (30,965,464)
Ending balance at Dec. 31, 2018 937,921   $ 3,009   108,485,219   (107,550,307)
Balance (in shares) at Dec. 31, 2018     30,087,213        
Stock-based compensation 6,115,160       6,115,160    
Issuance of common stock upon exercise of options 1,143,841   $ 25   1,143,816    
Issuance of common stock upon exercise of options (in shares)     252,773        
Exercise of warrants 249,836   $ 10   249,826    
Exercise of warrants (in shares)     97,541        
Issuance of warrants upon debt financing 387,000       387,000    
Issuance of common stock upon financing 238,233,817   $ 649   238,233,168    
Issuance of common stock upon financing (in shares)     6,495,690        
Net loss (68,345,186)           (68,345,186)
Ending balance at Dec. 31, 2019 $ 178,722,389   $ 3,693   354,614,189   (175,895,493)
Balance (in shares) at Dec. 31, 2019 36,933,217   36,933,217        
Stock-based compensation $ 14,756,206       14,756,206    
Issuance of common stock upon exercise of options $ 1,049,849   $ 13   1,049,836    
Issuance of common stock upon exercise of options (in shares) 127,778   127,778        
Exercise of warrants $ 6   $ 6        
Exercise of warrants (in shares)     63,831        
Issuance of warrants upon debt financing 884,216       884,216    
Issuance of common stock upon financing 14,125,506 $ 7,155,337 $ 17 $ 8 14,125,489 $ 7,155,329  
Issuance of common stock upon financing (in shares)     167,243 82,019      
Net loss (102,900,600)           (102,900,600)
Ending balance at Dec. 31, 2020 $ 113,792,909   $ 3,737   $ 392,585,265   $ (278,796,093)
Balance (in shares) at Dec. 31, 2020 37,374,088   37,374,088